Manipal Health IPO Subscription Hits 50%: Analysts Weigh In Amid Investor Demand
The Initial Public Offering (IPO) of Manipal Health Enterprises saw a subdued response as of the final day of bidding. The issue reached a subscription level of 50 percent according to data from the National Stock Exchange (NSE). This development puts scrutiny on the IPO’s valuation amid significant interest from institutional investors.Subscription and Allocation Details
The public issue, totaling Rs 9,275 crore, received bids for 4,38,85,675 shares against an offering of 9,00,88,286 shares. Qualified Institutional Buyers (QIBs) led the subscription segment, booking a portion that measured 62 percent.The retail investor (RII) category was subscribed at 54 percent, while the Non-Institutional Investor (NII) portion garnered an 18 percent subscription rate. Investors should note that the grey market premium (GMP) remained muted, commanding Rs 5 per share on the morning of July 31.
Valuation and Financial Snapshot
The IPO is priced within the range of Rs 560 to Rs 590 per equity share. The offering structure includes a fresh issue of 13.56 crore equity shares, valued at Rs 8,000 crore. This is complemented by an Offer For Sale (OFS) comprising 2.16 crore shares from existing shareholders, including TPG and Novo Holdings.In terms of financial performance for the fiscal year ended March 31, 2026, Manipal Health Enterprises reported revenue from operations of Rs 10,335.75 crore. This represents a significant increase compared to the previous financial year's revenue of Rs 8,242.25 crore.
Expert Opinions on Long-Term Growth
Analyst views remain varied regarding the IPO’s pricing. Brokerage firm Master Capital Services assigned a favorable view, noting that Manipal Health is strategically positioned to benefit from growing healthcare demand across India.The company’s pan-India network and focus on tertiary and quaternary care were highlighted as key strengths by the brokerage firm. Anand Rathi noted that while the IPO appears fully priced at the upper end of the price band, the long-term growth potential of the company remains supportive of an investment.
Company Operations and Future Plans
Manipal Health Enterprises operates a comprehensive network across India, including clinics, diagnostic centres, and multi-specialty hospitals. As of March 2026, the entity operated 49 hospitals, equipped with 13,037 licensed beds spanning 14 states and union territories.The IPO proceeds are slated to be utilized for several critical purposes. The company plans to use funds primarily to repay outstanding borrowings of its subsidiary, Manipal Hospitals Private Ltd. It will also acquire a minority stake in Sahyadri Hospitals Private and meet general corporate needs.
Listing Timeline and Investor Guidance
The IPO opened on July 29 and is scheduled to close on July 31. The basis of allotment for the issue is expected to be finalized on August 3. Shares are tentatively scheduled to list on both the BSE and NSE starting August 5, providing a market entry point. Investors are advised that GMP is an unofficial indicator and should not be considered a reliable measure of company fundamentals or future stock performance.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.